Laparoendoscopic single-site and natural orifice transluminal endoscopic surgery in urology: A critical analysis of the literature

Riccardo Autorino, Jeffrey A Cadeddu, Mihir M. Desai, Matthew Gettman, Inderbir S. Gill, Louis R. Kavoussi, Estevão Lima, Francesco Montorsi, Lee Richstone, Jens U. Stolzenburg, Jihad H. Kaouk

Research output: Contribution to journalArticle

210 Citations (Scopus)

Abstract

Context: Natural orifice transluminal endoscopic surgery (NOTES) and laparoendoscopic single-site surgery (LESS) have been developed to benefit patients by enabling surgeons to perform scarless surgery. Objective: To summarize and critically analyze the available evidence on the current status and future perspectives of LESS and NOTES in urology. Evidence acquisition: A comprehensive electronic literature search was conducted in June 2010 using the Medline database to identify all publications relating to NOTES and LESS in urology. Evidence synthesis: In urology, NOTES has been completed experimentally via transgastric, transvaginal, transcolonic, and transvesical routes. Initial clinical experience has shown that NOTES urologic surgery using currently available instruments is indeed possible. Nevertheless, because of the immaturity of the instrumentation, early cases have demanded high technical virtuosity. LESS can safely and effectively be performed in a variety of urologic settings. As clinical experience increases, expanding indications are expected to be documented and the efficacy of the procedure to improve. So far, the quality of evidence of all available studies remains low, mostly being small case series or case-control studies from selected centers. Thus, the only objective benefit of LESS remains the improved cosmetic outcome. Prospective, randomized studies are largely awaited to determine which LESS procedures will be established and which are unlikely to stand the test of time. Technology advances hold promise to minimize the challenging technical nature of scarless surgery. In this respect, robotics is likely to drive a major paradigm shift in the development of LESS and NOTES. Conclusions: NOTES is still an investigational approach in urology. LESS has proven to be immediately applicable in the clinical field, being safe and feasible in the hands of experienced laparoscopic surgeons. Development of instrumentation and application of robotic technology are expected to define the actual role of these techniques in minimally invasive urologic surgery.

Original languageEnglish (US)
Pages (from-to)26-45
Number of pages20
JournalEuropean Urology
Volume59
Issue number1
DOIs
StatePublished - Jan 2011

Fingerprint

Natural Orifice Endoscopic Surgery
Urology
Robotics
Technology
Minimally Invasive Surgical Procedures
Cosmetics
Publications
Case-Control Studies

Keywords

  • Laparoendoscopic single-site surgery
  • Laparoscopy
  • LESS
  • Natural orifice transluminal endoscopic surgery
  • NOTES
  • Robotics
  • Urology

ASJC Scopus subject areas

  • Urology

Cite this

Laparoendoscopic single-site and natural orifice transluminal endoscopic surgery in urology : A critical analysis of the literature. / Autorino, Riccardo; Cadeddu, Jeffrey A; Desai, Mihir M.; Gettman, Matthew; Gill, Inderbir S.; Kavoussi, Louis R.; Lima, Estevão; Montorsi, Francesco; Richstone, Lee; Stolzenburg, Jens U.; Kaouk, Jihad H.

In: European Urology, Vol. 59, No. 1, 01.2011, p. 26-45.

Research output: Contribution to journalArticle

Autorino, R, Cadeddu, JA, Desai, MM, Gettman, M, Gill, IS, Kavoussi, LR, Lima, E, Montorsi, F, Richstone, L, Stolzenburg, JU & Kaouk, JH 2011, 'Laparoendoscopic single-site and natural orifice transluminal endoscopic surgery in urology: A critical analysis of the literature', European Urology, vol. 59, no. 1, pp. 26-45. https://doi.org/10.1016/j.eururo.2010.08.030
Autorino, Riccardo ; Cadeddu, Jeffrey A ; Desai, Mihir M. ; Gettman, Matthew ; Gill, Inderbir S. ; Kavoussi, Louis R. ; Lima, Estevão ; Montorsi, Francesco ; Richstone, Lee ; Stolzenburg, Jens U. ; Kaouk, Jihad H. / Laparoendoscopic single-site and natural orifice transluminal endoscopic surgery in urology : A critical analysis of the literature. In: European Urology. 2011 ; Vol. 59, No. 1. pp. 26-45.
@article{908cb2d399944c31b21617add0f97c48,
title = "Laparoendoscopic single-site and natural orifice transluminal endoscopic surgery in urology: A critical analysis of the literature",
abstract = "Context: Natural orifice transluminal endoscopic surgery (NOTES) and laparoendoscopic single-site surgery (LESS) have been developed to benefit patients by enabling surgeons to perform scarless surgery. Objective: To summarize and critically analyze the available evidence on the current status and future perspectives of LESS and NOTES in urology. Evidence acquisition: A comprehensive electronic literature search was conducted in June 2010 using the Medline database to identify all publications relating to NOTES and LESS in urology. Evidence synthesis: In urology, NOTES has been completed experimentally via transgastric, transvaginal, transcolonic, and transvesical routes. Initial clinical experience has shown that NOTES urologic surgery using currently available instruments is indeed possible. Nevertheless, because of the immaturity of the instrumentation, early cases have demanded high technical virtuosity. LESS can safely and effectively be performed in a variety of urologic settings. As clinical experience increases, expanding indications are expected to be documented and the efficacy of the procedure to improve. So far, the quality of evidence of all available studies remains low, mostly being small case series or case-control studies from selected centers. Thus, the only objective benefit of LESS remains the improved cosmetic outcome. Prospective, randomized studies are largely awaited to determine which LESS procedures will be established and which are unlikely to stand the test of time. Technology advances hold promise to minimize the challenging technical nature of scarless surgery. In this respect, robotics is likely to drive a major paradigm shift in the development of LESS and NOTES. Conclusions: NOTES is still an investigational approach in urology. LESS has proven to be immediately applicable in the clinical field, being safe and feasible in the hands of experienced laparoscopic surgeons. Development of instrumentation and application of robotic technology are expected to define the actual role of these techniques in minimally invasive urologic surgery.",
keywords = "Laparoendoscopic single-site surgery, Laparoscopy, LESS, Natural orifice transluminal endoscopic surgery, NOTES, Robotics, Urology",
author = "Riccardo Autorino and Cadeddu, {Jeffrey A} and Desai, {Mihir M.} and Matthew Gettman and Gill, {Inderbir S.} and Kavoussi, {Louis R.} and Estev{\~a}o Lima and Francesco Montorsi and Lee Richstone and Stolzenburg, {Jens U.} and Kaouk, {Jihad H.}",
year = "2011",
month = "1",
doi = "10.1016/j.eururo.2010.08.030",
language = "English (US)",
volume = "59",
pages = "26--45",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Laparoendoscopic single-site and natural orifice transluminal endoscopic surgery in urology

T2 - A critical analysis of the literature

AU - Autorino, Riccardo

AU - Cadeddu, Jeffrey A

AU - Desai, Mihir M.

AU - Gettman, Matthew

AU - Gill, Inderbir S.

AU - Kavoussi, Louis R.

AU - Lima, Estevão

AU - Montorsi, Francesco

AU - Richstone, Lee

AU - Stolzenburg, Jens U.

AU - Kaouk, Jihad H.

PY - 2011/1

Y1 - 2011/1

N2 - Context: Natural orifice transluminal endoscopic surgery (NOTES) and laparoendoscopic single-site surgery (LESS) have been developed to benefit patients by enabling surgeons to perform scarless surgery. Objective: To summarize and critically analyze the available evidence on the current status and future perspectives of LESS and NOTES in urology. Evidence acquisition: A comprehensive electronic literature search was conducted in June 2010 using the Medline database to identify all publications relating to NOTES and LESS in urology. Evidence synthesis: In urology, NOTES has been completed experimentally via transgastric, transvaginal, transcolonic, and transvesical routes. Initial clinical experience has shown that NOTES urologic surgery using currently available instruments is indeed possible. Nevertheless, because of the immaturity of the instrumentation, early cases have demanded high technical virtuosity. LESS can safely and effectively be performed in a variety of urologic settings. As clinical experience increases, expanding indications are expected to be documented and the efficacy of the procedure to improve. So far, the quality of evidence of all available studies remains low, mostly being small case series or case-control studies from selected centers. Thus, the only objective benefit of LESS remains the improved cosmetic outcome. Prospective, randomized studies are largely awaited to determine which LESS procedures will be established and which are unlikely to stand the test of time. Technology advances hold promise to minimize the challenging technical nature of scarless surgery. In this respect, robotics is likely to drive a major paradigm shift in the development of LESS and NOTES. Conclusions: NOTES is still an investigational approach in urology. LESS has proven to be immediately applicable in the clinical field, being safe and feasible in the hands of experienced laparoscopic surgeons. Development of instrumentation and application of robotic technology are expected to define the actual role of these techniques in minimally invasive urologic surgery.

AB - Context: Natural orifice transluminal endoscopic surgery (NOTES) and laparoendoscopic single-site surgery (LESS) have been developed to benefit patients by enabling surgeons to perform scarless surgery. Objective: To summarize and critically analyze the available evidence on the current status and future perspectives of LESS and NOTES in urology. Evidence acquisition: A comprehensive electronic literature search was conducted in June 2010 using the Medline database to identify all publications relating to NOTES and LESS in urology. Evidence synthesis: In urology, NOTES has been completed experimentally via transgastric, transvaginal, transcolonic, and transvesical routes. Initial clinical experience has shown that NOTES urologic surgery using currently available instruments is indeed possible. Nevertheless, because of the immaturity of the instrumentation, early cases have demanded high technical virtuosity. LESS can safely and effectively be performed in a variety of urologic settings. As clinical experience increases, expanding indications are expected to be documented and the efficacy of the procedure to improve. So far, the quality of evidence of all available studies remains low, mostly being small case series or case-control studies from selected centers. Thus, the only objective benefit of LESS remains the improved cosmetic outcome. Prospective, randomized studies are largely awaited to determine which LESS procedures will be established and which are unlikely to stand the test of time. Technology advances hold promise to minimize the challenging technical nature of scarless surgery. In this respect, robotics is likely to drive a major paradigm shift in the development of LESS and NOTES. Conclusions: NOTES is still an investigational approach in urology. LESS has proven to be immediately applicable in the clinical field, being safe and feasible in the hands of experienced laparoscopic surgeons. Development of instrumentation and application of robotic technology are expected to define the actual role of these techniques in minimally invasive urologic surgery.

KW - Laparoendoscopic single-site surgery

KW - Laparoscopy

KW - LESS

KW - Natural orifice transluminal endoscopic surgery

KW - NOTES

KW - Robotics

KW - Urology

UR - http://www.scopus.com/inward/record.url?scp=78650240391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650240391&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2010.08.030

DO - 10.1016/j.eururo.2010.08.030

M3 - Article

C2 - 20828918

AN - SCOPUS:78650240391

VL - 59

SP - 26

EP - 45

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - 1

ER -